Homocysteine, renal function, and risk of cardiovascular disease.

Homocysteine, renal function, and risk of cardiovascular disease.

BACKGROUND: Patients with renal impairment have markedly elevated homocysteine levels and are at particularly high risk of ischemic heart disease (IHD) and stroke, but the relevance of elevated homocysteine levels in this population is uncertain. METHODS: We examined the association with IHD from a...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Clarke, R, Lewington, S, Landray, M
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	2003

Míreanna comhchosúla

Homocysteine and risk of cardiovascular disease and venous thrombosis
de réir: Clarke, R, et al.
Foilsithe / Cruthaithe: (2003)

Effects of B-vitamins on plasma homocysteine concentrations and on risk of cardiovascular disease and dementia.
de réir: Clarke, R, et al.
Foilsithe / Cruthaithe: (2007)

Homocysteine and coronary heart disease.
de réir: Clarke, R, et al.
Foilsithe / Cruthaithe: (2002)

Homocysteine, B vitamins, and the risk of cardiovascular disease.
de réir: Clarke, R
Foilsithe / Cruthaithe: (2011)

Homocysteine and prediction of coronary heart disease and stroke
de réir: Clarke, R, et al.
Foilsithe / Cruthaithe: (2003)

Underestimation of the importance of homocysteine as a risk factor for cardiovascular disease in epidemiological studies.
de réir: Clarke, R, et al.
Foilsithe / Cruthaithe: (2001)

Homocysteine and vascular disease: Review of published results of the homocysteine-lowering trials
de réir: Clarke, R, et al.
Foilsithe / Cruthaithe: (2011)

Homocysteine and vascular disease: review of published results of the homocysteine-lowering trials.
de réir: Clarke, R, et al.
Foilsithe / Cruthaithe: (2011)

Homocysteine and cardiovascular disease. Overview.
de réir: Clarke, R
Foilsithe / Cruthaithe: (1998)

Renal function: an emerging risk factor for cardiovascular disease?
de réir: Landray, M, et al.
Foilsithe / Cruthaithe: (2001)

Homocysteine, B-vitamins, and the risk of cardiovascular disease.
de réir: Clarke, R, et al.
Foilsithe / Cruthaithe: (2005)

Homocysteine-lowering And Cardiovascular Disease: Is The Door Closing Now
de réir: Clarke, R
Foilsithe / Cruthaithe: (2009)

Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies.
de réir: Den Heijer, M, et al.
Foilsithe / Cruthaithe: (2005)

Commentary: an updated review of the published studies of homocysteine and cardiovascular disease.
de réir: Clarke, R
Foilsithe / Cruthaithe: (2002)

Assessment of homocysteine as a cardiovascular risk factor in clinical practice.
de réir: Clarke, R, et al.
Foilsithe / Cruthaithe: (2001)

Homocysteine and cardiovascular disease
de réir: p yavari
Foilsithe / Cruthaithe: (2000-06-01)

Homocysteine and cardiovascular disease
Foilsithe / Cruthaithe: (2000-05-01)

Homocysteine-lowering trials for prevention of vascular disease: protocol for a collaborative meta-analysis.
de réir: Clarke, R, et al.
Foilsithe / Cruthaithe: (2007)

Combined effects of systolic blood pressure and total cholesterol on cardiovascular disease risk
de réir: Lewington, S, et al.
Foilsithe / Cruthaithe: (2005)

Combined effects of systolic blood pressure and total cholesterol on cardiovascular disease risk.
de réir: Lewington, S, et al.
Foilsithe / Cruthaithe: (2005)

HOMOCYSTEINE, LARGE ARTERIES AND CARDIOVASCULAR RISK
de réir: Jan Filipovský
Foilsithe / Cruthaithe: (2007-08-01)

Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements.
de réir: Clarke, R, et al.
Foilsithe / Cruthaithe: (2000)

Homocysteine, grey matter and cognitive function in adults with cardiovascular disease.
de réir: Andrew H Ford, et al.
Foilsithe / Cruthaithe: (2012-01-01)

Homocysteine, B vitamins, and cardiovascular disease
de réir: Refsum, H, et al.
Foilsithe / Cruthaithe: (2006)

Homocysteine, B vitamins, and cardiovascular disease.
de réir: Refsum, H, et al.
Foilsithe / Cruthaithe: (2006)

Homocysteine, B vitamins, and the risk of dementia.
de réir: Clarke, R
Foilsithe / Cruthaithe: (2007)

Homocysteine, the kidney, and vascular disease.
de réir: Haynes, R, et al.
Foilsithe / Cruthaithe: (2012)

Plasma homocysteine and coronary heart disease: systematic review of published epidemiological studies.
de réir: Danesh, J, et al.
Foilsithe / Cruthaithe: (1998)

Homocysteine, the kidney, and vascular disease Moderate differences in homocysteine concentrations do not cause vascular disease
de réir: Haynes, R, et al.
Foilsithe / Cruthaithe: (2012)

Homocysteine and cardiovascular risk: considering the evidence in the context of study design, folate fortification, and statistical power.
de réir: Ueland, P, et al.
Foilsithe / Cruthaithe: (2007)

Elevated homocysteine and differential risks of the renal function decline in hypertensive patients
de réir: Chunlei Liu, et al.
Foilsithe / Cruthaithe: (2020-08-01)

Uncontrolled hypertension and risk of cardiovascular mortality in China-reply
de réir: Lewington, S, et al.
Foilsithe / Cruthaithe: (2016)

Therapeutical approach to plasma homocysteine and cardiovascular risk reduction
de réir: Marcello Ciaccio, et al.
Foilsithe / Cruthaithe: (2008-03-01)

Can dietary supplements with folic acid or vitamin B6 reduce cardiovascular risk? Design of clinical trials to test the homocysteine hypothesis of vascular disease.
de réir: Clarke, R, et al.
Foilsithe / Cruthaithe: (1998)

Homocysteine-lowering trials for prevention of heart disease and stroke.
de réir: Clarke, R
Foilsithe / Cruthaithe: (2005)

Plasma homocysteine, type 2 diabetes and risk of coronary heart disease in the UKPDS
de réir: Holman, R, et al.
Foilsithe / Cruthaithe: (2001)

Homocysteine as a risk factor for cardiovascular disease: should we (still) worry about?
de réir: Swiss Medical Weekly
Foilsithe / Cruthaithe: (2006-12-01)

Homocysteine and malondialdeyde (MDA) levels associated with the occurrence of cardiovascular disease (CVD) in chronic renal failure (CRF) in Malaysia.
de réir: Arab, Shahin, et al.
Foilsithe / Cruthaithe: (2011)

Which cardiovascular risk factors matter in chronic kidney disease?
de réir: Baigent, C, et al.
Foilsithe / Cruthaithe: (2007)

Detecting homocysteine in cardiovascular disease using aptasensors: A review
de réir: Sara Ranjbari, et al.
Foilsithe / Cruthaithe: (2023-12-01)